Spain promotes genomics and medtech R&D
This article was originally published in Clinica
Spain plans to provide an additional Pta8 billion ($44 million) in each of the next three years for genomics and proteomics research. The allocation was decided last week by the government's science and technology committee (CICYT), chaired by the prime minister, Jose Maria Aznar.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.